Stay updated on Nivolumab for Oral Proliferative Verrucous Leukoplakia Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Oral Proliferative Verrucous Leukoplakia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Oral Proliferative Verrucous Leukoplakia Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.4, signifying a small metadata/documentation update rather than a substantive change to content.
    Difference
    0.1%
    Check dated 2026-05-15T03:14:57.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.5.3 was added and Revision: v3.5.2 was removed, signaling a newer version of the study protocol/documents has been issued.
    Difference
    0.1%
    Check dated 2026-04-30T18:09:50.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added. Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T09:23:58.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0. Previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-25T15:26:08.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updated on the page, replacing the prior v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:28:53.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the notices about funding lapse and Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T02:16:06.000Z thumbnail image

Stay in the know with updates to Nivolumab for Oral Proliferative Verrucous Leukoplakia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Oral Proliferative Verrucous Leukoplakia Clinical Trial page.